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A B S T R A C T
Tuberculosis (TB) is one of the leading causes of morbidity and mortality worldwide. Early diagnosis and
treatment are key to prevent Mycobacterium tuberculosis transmission. Bronchoscopy can play a primary
role in pulmonary TB diagnosis, particularly for suspected patients with scarce sputum or sputum smear
negativity, and with endobronchial disease. Bronchoscopic needle aspiration techniques are accurate and
safe means adopted to investigate hilar and mediastinal lymph nodes in cases of suspected TB
lymphadenopathy. Tracheobronchial stenosis represents the worst complication of endobronchial
tuberculosis. Bronchoscopic procedures are less invasive therapeutic strategies than conventional
surgery to be adopted in the management of TB-related stenosis.
We conducted a non-systematic review aimed at describing the scientiﬁc literature on the role of
bronchoscopic techniques in the diagnosis and therapy of patients with TB.
We focused on three main areas of interventions: bronchoscopic diagnosis of smear negative/sputum
scarce TB patients, endobronchial TB diagnosis and treatment and needle aspiration techniques for
intrathoracic TB lymphadenopathy. We described experiences on bronchoalveolar lavage, bronchial
washing, and biopsy techniques for the diagnosis of patients with tracheobronchial and pulmonary TB;
furthermore, we described the role played by conventional and ultrasound-guided transbronchial needle
aspiration in the diagnosis of suspected hilar and mediastinal TB adenopathy. Finally, we assessed the role
of the bronchoscopic therapy in the treatment of endobronchial TB and its complications, focusing on
dilation techniques (such as balloon dilation and airway stenting) and ablative procedures (both heat and
cold therapies).
© 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Tuberculosis (TB) is one of the most important infectious
diseases worldwide (World Health Organization, 2016). Its
epidemiological burden is relevant in terms of morbidity and
mortality. In particular, the last World Health Organization (WHO)
Global Report on TB, published in 2016, highlighted an increased
incidence (10.4 million) and mortality (1.4 million) in 2015 in
comparison with the estimated ﬁgures reported in the previous
year (World Health Organization, 2016). The new public health
WHO strategy (World Health Organization, 2014; D’Ambrosio
et al., 2014; Lönnroth et al., 2015; Sotgiu and Migliori, 2014), named
End TB Strategy and aimed at eliminating TB, can achieve its goal by
2050 only if new cases of active disease are prevented (through
vaccination and treatment of individuals with latent TB infection)
or early detected and appropriately treated. The current diagnostic
and therapeutic weapons are old and frequently ineffective (e.g.,
sputum smear negative patients, drug-resistant cases). Intensiﬁed
research and development activities in the diagnostic, therapeutic,
and preventive ﬁeld could signiﬁcantly address the current
operational issues.
An appropriate therapeutic prescription strongly relies on
microbiologic diagnosis of the collected biological specimen (i.e.,
liquid or solid culture) (World Health Organization, 2006).
Several factors can hinder the collection of specimens and, then,
the deﬁnitive diagnosis. In case of pulmonary TB, at least two
sputum specimens are required; however, in some groups of
patients (for instance, children, HIV-positive patients) the collec-
tion is difﬁcult and alternative methods are necessary (World
Health Organization, 2006; Dheda et al., 2004). Until now,
observational and experimental studies have not provided
sufﬁcient scientiﬁc evidence to recommend one speciﬁc method
more than another.
One of the medical interventions which could improve the
clinical management of the TB patients is the bronchoscopy
(Theron et al., 2013).
Aim of the present review is to describe the most important
studies on bronchoscopy in the TB ﬁeld and its potential
recommendations.
Methods
We carried out a non-systematic, narrative literature review
based on a Pubmed search until June 2017. We selected only
epidemiological studies performed in adult human beings and
written in English. Other ﬁlters, including those related to the aim
of the study, were not used.
Bronchoscopy and diagnosis of sputum smear negative/sputum
scarce TB patients
Sputum smear microscopy is the easiest and widespread tool
adopted globally to diagnose cases of pulmonary TB; however,
although it has been recommended since the ﬁrst WHO global TB
strategy (i.e., DOTS), its sensitivity can be poor and affected by
specimen processing methods and technical skills (World Health
Organization, 2006; Steingart et al., 2006). Notably, more than one
third of patients with pulmonary TB cannot produce sufﬁcient
sputum or is sputum smear negative (Theron et al., 2013; Heppleet al., 2012). Even though sputum induction is frequently used, it
fails to provide a specimen of adequate volume or quality in up to
20% of the cases (Hepple et al., 2012). Moreover, it is not allowed to
explore the airways and collect samples from the low respiratory
tract (Theron et al., 2013). Bronchoscopy with bronchial washing
(BW), bronchoalveolar lavage (BAL), and biopsy can play a key role
in the collection of suitable samples for TB diagnosis (Lewinsohn
et al., 2017).
Chest radiology (i.e., chest X-ray and chest computed tomogra-
phy) is helpful to plan and guide the collection of bronchoscopic
samples; it can show parenchymal features (e.g., consolidations,
cavitations, scattered nodules, etc.) and endobronchial involve-
ments, as well as hilar and mediastinal lymph nodes enlargements
(Beigelman et al., 2000; Skoura et al., 2015; Burrill et al., 2007). On
the other side, F-FDG PET/CT (18F-ﬂuorodeoxyglucose positron
emission tomography/computed tomography) may help detect
active TB (Skoura et al., 2015).
Bronchoscopic diagnosis of pulmonary TB traditionally relies on
acid-fast bacilli smear microscopy, nucleic acid ampliﬁcation
techniques (NAATs), and Mycobacterium tuberculosis cultures
(Theron et al., 2013; Jafari et al., 2011; Jafari et al., 2009; Jafari
et al., 2006; Tueller et al., 2005; Mok et al., 2016; Tamura et al.,
2010). Transbronchial needle aspiration (Reichenberger et al.,
1999) and transbronchial biopsy (Theron et al., 2013; Chan et al.,
2015; Jacomelli et al., 2012) may support the detection of
cytological and histological TB ﬁndings (i.e., necrotizing granulo-
matous inﬂammation), but a positive culture is associated with the
highest diagnostic accuracy (Theron et al., 2013; World Health
Organization, 2015). Indeed, mycobacterial culture could provide
further information on drug sensitivity (World Health Organiza-
tion, 2015).
However, the diagnostic delay related to a time to positivity
ranging from 2 to 6 weeks (Theron et al., 2013; Mok et al., 2016;
Dheda et al., 2009) increases the probability of a poor prognosis
(morbidity, mortality, and economic burden) and of Mycobacterium
tuberculosis transmission (Theron et al., 2013; Jafari et al., 2009;
Tueller et al., 2005; Dheda et al., 2009; Le Palud et al., 2014). Smear
microscopy for the identiﬁcation of acid-fast bacilli is rapid (one-
two days) and inexpensive (Mok et al., 2016), but its bacillary load-
related sensitivity based on bronchoscopic specimens is low
(Theron et al., 2013; Jafari et al., 2011; Jafari et al., 2009; Jafari et al.,
2006; Tueller et al., 2005; Reichenberger et al., 1999; Chan et al.,
2015; Jacomelli et al., 2012; Dheda et al., 2009; Le Palud et al., 2014;
Barnard et al., 2015; Lee et al., 2013; Lin et al., 2010). NAAT, aimed to
detect Mycobacterium tuberculosis nucleic acids, and histology have
a good diagnostic yield, providing a response in a few days (Theron
et al., 2013; Jafari et al., 2011; Jafari et al., 2009; Jafari et al., 2006;
Tueller et al., 2005; Mok et al., 2016; Tamura et al., 2010; Chan et al.,
2015; Jacomelli et al., 2012). The combination of those techniques
may signiﬁcantly increase the sensitivity of bronchoscopy for the
early diagnosis of pulmonary TB (Theron et al., 2013; Tueller et al.,
2005; Mok et al., 2016; Tamura et al., 2010; Jacomelli et al., 2012).
The main shortcoming of those techniques using sputum and
bronchoscopic materials can be the low speciﬁcity.
Rapid on-site evaluation (ROSE) of transbronchial needle
aspirates is a well-known predictor of better yield in peripheral
pulmonary lesions sampling (Mondoni et al., 2016a). Furthermore,
for the diagnosis of endobronchial malignancies, parenchymal
lesions and hilar/mediastinal lymphadenopathies, ROSE technique
may allow bronchoscopists to interrupt the sampling procedure
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passes and/or useless transbronchial biopsies or brushings (Mon-
doni et al., 2013; Mondoni et al., 2016a; Trisolini et al., 2011;
Gasparini et al.,1995). In TB diagnosis ROSE may be useful to rapidly
detect TB-related granulomas (Gasparini et al.,1995). Unfortunately,
no methods are currently available for the immediate detection of
mycobacteria in respiratory samples (Lewinsohn et al., 2017).
Bronchoalveolar lavage and bronchial washing aspirate
Smear microscopy shows a sensitivity ranging between 4.7%
and 58.0% on BAL and BW (Theron et al., 2013; Jafari et al., 2009;
Tueller et al., 2005; Dheda et al., 2009; Le Palud et al., 2014;
Barnard et al., 2015; Lee et al., 2013; Lin et al., 2010; Ko et al., 2016;
Agrawal et al., 2016; Khalil and Butt, 2015).
The NAAT sensitivity signiﬁcantly varies when carried out on
BW (51.9%-97.2%) (Tamura et al., 2010; Lee et al., 2011; Min et al.,
2010; Wong et al., 1998; Chen et al., 2002; Boehme et al., 2010) and
BAL (31.3-83.8%) (Jafari et al., 2011; Jafari et al., 2009; Tueller et al.,
2005; Mondoni et al., 2016a; Chen et al., 2002), whereas the
speciﬁcity is higher than 70% (73.2-100.0%) on BW (Tamura et al.,
2010; Lee et al., 2011; Min et al., 2010; Wong et al.,1998; Chen et al.,
2002) and 92.4-98.2% on BAL (Jafari et al., 2011; Jafari et al., 2009;
Tueller et al., 2005; Dheda et al., 2009; Ko et al., 2016; Chen et al.,
2002), respectively. The mismatch between sensitivity and
speciﬁcity might be partially explained from the reference to
different standards in the retrieved studies (single or combined use
of microbiological, clinical and histological data) (Jafari et al., 2011;
Jafari et al., 2009; Tueller et al., 2005; Tamura et al., 2010; Ko et al.,
2016; Lee et al., 2011; Min et al., 2010; Wong et al.,1998; Chen et al.,
2002).
Xpert1MTB/RIF (Cepheid Inc, Sunnyvale, California, USA) assay,
a single cartridge-based NAAT, can simultaneously detect Myco-
bacterium tuberculosis nucleic acids and its genetic rifampicin
(RMP) resistence within 2–3 hours (Boehme et al., 2010; World
Health Organization, 2011). In comparison with the other
commercially available NAATs, it is based on a fully-automated
process (Theron et al., 2013; Le Palud et al., 2014; Boehme et al.,
2010; World Health Organization, 2011; Sharma et al., 2015; AlbertTable 1
Summary of studies evaluating the diagnostic performance of Xpert1MTB/RIF on bron
Author/year Country Study
design
Patients
number
Bronchos
specimen
Theron et al. (2013) South Africa PCS 27 BAL 
Lee et al. (2013) Republic of
Korea
RCS 38 BAL and B
Le Palud et al. (2014) France RCS 23 BAL and B
Dhasmana et al. (2014) Great Britain RCS 84 EBUS-TBN
Barnard et al. (2015) South Africa RCS 39 BW 
Khalil and Butt (2015) Pakistan RCS 85 BAL 
Agrawal et al. (2016) India RCS 27 BAL 
Ko et al. (2016) Republic of
Korea
RCS 105 BAL and B
Sharma et al. (2015) India PCS BAL: 127
BW: 4
BAL and B
Mok et al. (2016) Singapore RCS 44 BAL 
Jo et al. (2016) Republic of
Korea
RCS 64 BW 
Dhooria et al. (2016a) India RCS 53 EBUS-TBN
Lee et al. (2017) Republic of
Korea
RCS 10 EBUS-TBN
Ullah et al. (2017) Pakistan PCS 98 BAL 
PCS: prospective cohort study; RCS: retrospective cohort study; TB: tuberculosis; BA
ultrasounds-transbronchial needle aspiration; NR: not reported.et al., 2016). Its diagnostic accuracy was widely conﬁrmed on
sputum specimens; however, in recent years its performance was
successfully assessed on bronchoscopic specimens such as BW (Le
Palud et al., 2014; Barnard et al., 2015; Lee et al., 2013; Ko et al.,
2016; Sharma et al., 2015; Jo et al., 2016), BAL (Theron et al., 2013;
Mok et al., 2016; Le Palud et al., 2014; Lee et al., 2013; Ko et al.,
2016; Agrawal et al., 2016; Khalil and Butt, 2015; Sharma et al.,
2015; Ullah et al., 2017), and endobronchial ultrasound guided-
transbronchial needle aspiration (EBUS-TBNA) (Dhasmana et al.,
2014; Dhooria et al., 2016a; Lee et al., 2017) (Table 1).
Theron et al. ﬁrstly demonstrated the high diagnostic accuracy
of Xpert1MTB/RIF on BAL (Theron et al., 2013). In a high TB
incidence country (South Africa), the Authors prospectively
enrolled 160 sputum scarce or smear-negative patients with
suspected pulmonary TB, who underwent bronchoscopy with BAL.
Out of 27 patients with BAL culture positive for Mycobacterium
tuberculosis, Xpert1MTB/RIF showed a sensitivity of 97%, signiﬁ-
cantly higher than that of smear microscopy performed on the
same specimen (58%). Deﬁnite diagnosis was done in more than
80% of sputum smear negative patients. HIV/TB co-infection (35%
of patients) did not affect sensitivity and speciﬁcity (Theron et al.,
2013). In contrast with the ﬁndings of Ko et al. (Ko et al., 2016), they
failed to demonstrate a signiﬁcantly shorter treatment delay in
patients with positive BAL Xpert.
Similar ﬁndings were shown by other Authors (Barnard et al.,
2015; Lee et al., 2013; Agrawal et al., 2016; Khalil and Butt, 2015;
Sharma et al., 2015; Jo et al., 2016; Ullah et al., 2017) who
retrospectively demonstrated a high sensitivity (81-100%) of
Xpert1MTB/RIF in both BW and BAL (Table 1).
Interestingly, Le Palud et al. (2014) conﬁrmed a high sensitivity
(80%) of the assay also in a low TB incidence country (France),
enrolling 23 culture-positive patients who underwent bronchos-
copy with BAL and BW for suspected pulmonary TB.
However, Barnard et al. (2015) reported on a lower speciﬁcity
(87.7%): 9 patients resulted Xpert positive and culture negative
(with a very low cycle threshold value), with three of them
previously treated for pulmonary TB and one infected by
Mycobacterium avium intracellulare. They highlight the importance
of culture conﬁrmation, as well as the medical history of a previouschoscopic specimens.
copic Sensitivity Speciﬁcity Reference standard
92.6% 96% Culture
W 81.6% 100% Culture
W 80% 98.6% Culture
A 72.6% NR Culture
92.3% 87.7% Culture
91.8% 71.4% Culture
81.4% 93.4% Culture
W 92.4% 91.7% Culture
W BAL: 90%
BW: 100%
BAL: 100%
BW: 100%
Culture
68% 98% Culture
92.2.4% 81.6% Culture
A 49.1% 97.9% AFB microscopy or culture
or histology and clinico-radiological
presentation and responses to
treatment
A 100% NR Culture or histology or NAAT (Xpert)
80% 87.5% Culture
L: bronchoalveolar lavage; BW: bronchial washing; EBUS-TBNA: endobronchial
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Khalil and Butt, 2015).
Ko et al. compared the accuracy of Xpert1MTB/RIF with
AdvanSureTM, a conventional real-time polymerase chain reaction
(PCR) in 105 culture-conﬁrmed pulmonary TB patients for whom
both PCR techniques were available on BAL and BW. Xpert1MTB/
RIF sensitivity was signiﬁcantly higher than that of the conven-
tional assay (92.4% vs. 83.8%, respectively) in smear negative
patients, without any signiﬁcant differences in smear positive
subjects (Ko et al., 2016). Similar ﬁndings were also demonstrated
by Jo et al. (2016).
Several studies demonstrated a high sensitivity (83.3-100.0%)
and speciﬁcity (97.7-100.0%) of Xpert in diagnosing RMP resistance
on both BAL and BW (Theron et al., 2013; Barnard et al., 2015; Lee
et al., 2013; Sharma et al., 2015; Ullah et al., 2017).
Interferon-gamma release assays (IGRAs) are being used
increasingly for the detection of an immune response against
Mycobacterium tuberculosis antigens. However, their diagnostic
accuracy (sub-optimal sensitivity and low speciﬁcity) for active TB
has been disappointing when performed on blood specimens,
especially in high TB incidence areas (Sester et al., 2011;
Cattamanchi et al., 2012). The identiﬁcation of a TB-speciﬁc
immune response at the site of disease (i.e. the lungs) might
improve IGRA performance, favouring an early diagnosis in AFB
smear negative/sputum scarce patients (Sester et al., 2011;
Cattamanchi et al., 2012).
Only a few studies have assessed the IGRAs on BAL specimens:
the ﬁrst ones, performed in low TB burden countries (Europe) with
a lowest HIV infection prevalence, demonostrated a sensitivity and
a speciﬁcity ranging from 91.0 to 100.0% and from 80.0-100.0%,
respectively, with a low rate of indeterminate results (5-9%) (Jafari
et al., 2011; Jafari et al., 2009; Jafari et al., 2006). Studies performed
in high HIV/TB incidence countries showed a lower accuracy and a
higher rate of indeterminate results (up to 34%) (Dheda et al., 2009;
Cattamanchi et al., 2012; Jafari et al., 2013). To date, its suboptimal
accuracy in BAL is limiting its scale-up (Sester et al., 2011;
Cattamanchi et al., 2012; Jafari et al., 2013).Figure 1. Chest computed tomography (A) and PET/CT scan (B) of a cavitated lesion in a p
and needle aspiration (D) of the lesion.Transbronchial biopsy techniques
Fluoroscopy-guided transbronchial forceps biopsy (TBB) has
long been used in diagnosing pulmonary TB in sputum-scarce or
smear negative patients with peripheral pulmonary lesions
(Figure 1). The histological feature of necrotizing granulomas
on transbronchial samples in adjunction with AFB examination
can shorten the TB diagnostic delay (Mok et al., 2016; Tamura
et al., 2010; Chan et al., 2015; Jacomelli et al., 2012; Willcox et al.,
1982). In case of missing contraindications, it was recommended
by several Authors to add on TBB to BAL in order to increase
bronchoscopy sensitivity (Mok et al., 2016; Tamura et al., 2010;
Jacomelli et al., 2012; Lin et al., 2010; Charoenratanakul et al.,
1995).
Several studies showed a TBB sensitivity of 16-77% in
association with a good safety proﬁle. Pneumothorax and bleeding
are the most frequently reported complications (Theron et al.,
2013; Mok et al., 2016; Tamura et al., 2010; Chan et al., 2015;
Jacomelli et al., 2012; Willcox et al., 1982; Charoenratanakul et al.,
1995; Wallace et al., 1981; Willcox et al., 1986; Danek and Bower,
1979; Stenson et al., 1983; Lai et al., 1996).
The wide inter-study variability of the diagnostic accuracy
might be explained by the heterogeneous TB diagnostic criteria
(i.e., histology, bacteriology, or their combination), lesions size, and
radiological features of the parenchymal lesions (Theron et al.,
2013; Mok et al., 2016; Tamura et al., 2010; Chan et al., 2015;
Jacomelli et al., 2012; Willcox et al., 1982; Charoenratanakul et al.,
1995; Wallace et al., 1981; Willcox et al., 1986; Danek and Bower,
1979; Stenson et al., 1983; Lai et al., 1996), with lesions sized >2 cm
(Lai et al., 1996) and miliary TB (Willcox et al., 1986; Burk et al.,
1978) associated with an improved yield.
Chan et al. described the highest sensitivity of TBB (77%) with
the guidance of radial probe endobronchial ultrasounds (Chan
et al., 2015), whereas Lin et al. showed that EBUS-guided TBB is
associated with a higher sensitivity than conventional ﬂuoroscop-
ically-guided samples (32.9% vs. 4.2%). Furthermore, in the
subgroup of lesions detected with EBUS probes, AFB smears andatient with tuberculosis; conventional ﬂuoroscopy-guided transbronchial biopsy (C)
Table 2
Factors potentially affecting the sensitivity of transbronchial biopsy in diagnosing
pulmonary tuberculosis.
Lesion size
Presence of miliary tuberculosis
Radial probe endobronchial ultrasounds-guidance
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group (Lin et al., 2010) (Table 2).
More recently, Mok et al. reported on the results of an
observational, retrospective study conducted in a tertiary hospital
in Singapore, where the diagnostic role of BAL Xpert on sputum
scarce and smear negative patients with pulmonary TB was
assessed (Mok et al., 2016). They conﬁrmed the good sensitivity of
Xpert assay on BAL (68%) and stated that when Xpert1 assay is
added to routine BAL analysis TBLB did not signiﬁcantly increase
early and overall diagnostic yield. However, TBLB has a higher yield
than BAL in diagnosing both interstitial lung diseases and
pulmonary cancers, i.e. in cases showing clinical and radiological
features that can closely resemble pulmonary TB. This technical
characteristic may be relevant in countries with a low TB incidence,
where the diagnosis of interstitial and malignant diseases is more
frequent than TB. Then, the replacement of TBLB might lead to
underdiagnosis of rapidly progressive and life-threatening medical
conditions (Mok et al., 2016; Jacomelli et al., 2012; Lin et al., 2010;
Mondoni et al., 2016b).
Other Authors reported on the utility of cytological specimens
containing typical granulomas collected through ﬂuoroscopically-
guided brushing and transbronchial needle aspiration in the
diagnosis of TB-related peripheral pulmonary nodules and masses
(Tamura et al., 2010; Reichenberger et al., 1999; Gasparini et al.,
1995; Jafari et al., 2013; Franzen et al., 2016) (Figure 1). Franzen
et al., who carried out a randomized controlled trial in a high TB
incidence country, failed to demonstrate a higher yield of brushing
and TBLB performed with an ultrathin bronchocope versus
samplings obtained with a standard bronchoscope (Franzen
et al., 2016).
To date only one case report has described the utility and safety
of transbronchial cryoprobes in diagnosing pulmonary TB and
discriminating it from other diffuse lung diseases (such as
sarcoidosis) in a high TB incidence setting (Dhooria et al.,
2016b). Cryoprobes might further enhance the diagnostic perfor-
mance of bronchoscopy in early and overall diagnosis of TB and
diseases closely resembling TB (Mondoni et al., 2016b; Dhooria
et al., 2016b) but future, controlled studies are needed.Figure 2. Tumorous endobronchial tuberculosis: endobronchial lesions covered with ca
stenosis (B).Bronchoscopy and endobronchial tuberculosis
Endobonchial TB (EBTB) is a TB form involving the tracheo-
bronchial tree (microbiological and histopathological evidence),
regardless of a parenchymal involvement (Kashyap and Solanki,
2014; Sahin and Yildiz, 2013). The estimated incidence of EBTB was
equal to 5.8%-50% (Altin et al.,1997; Chung and Lee, 2000; Lee et al.,
2010; Kurasawa et al., 1992; Jung et al., 2015) among all pulmonary
TB cases. However, since bronchoscopy is not routinely performed
in all TB patients, its true incidence is likely underestimated
(Kashyap and Solanki, 2014; Ozkaya et al., 2012). Bronchoscopy can
be relevant for its diagnosis. In this context the role of endoscopy is
complementary to chest CT, which evaluates the bronchial
involvement length and peribronchial thickness, as well as the
luminal patency. Furthermore, CT scans may detect indirect signs
of bronchial stenosis (i.e., atelectasis, cavities, hyperinﬂation,
obstructive pneumonias) and predict patient outcome after
bronchoscopic re-expansion procedures (Beigelman et al., 2000;
Skoura et al., 2015; Burrill et al., 2007; Kashyap and Solanki, 2014;
Chung and Lee, 2000; Lee and Chung, 2000). Since severe
complications have been described in patients with EBTB,
bronchoscopic examination of the tracheobronchial wall should
be prompt in case of persistent cough, haemoptysis, clinical signs
of bronchostenosis (such as wheezing and stridor), and radiologi-
cal suspicion of endobronchial micobacterial invasion (Kashyap
and Solanki, 2014; Lee et al., 2010; Hou et al., 2014).
On the basis of the bronchoscopic characteristics, endobron-
chial TB may be classiﬁed into seven categories, which are closely
related to pathological changes (Chung and Lee, 2000; Xue et al.,
2011) (Table 3).
Edematous-hyperemic, granular, and actively caseating sub-
types are the most frequently detected (Sahin and Yildiz, 2013;
Chung and Lee, 2000; Ozkaya et al., 2012; Qingliang and Jianxin,
2010; Um et al., 2008) but different subtypes may coexist in the
same patient and one subtype may change into another (Chung
and Lee, 2000; Xue et al., 2011). Bronchoscopic follow-up studies
demonstrated that the evolution of EBTB depends on initial
ﬁndings, which are closely related to the formation of granulation
tissue (Chung and Lee, 2000; Kim et al., 1993; Lee et al., 1992).
Fibrostenotic, actively caseating, edematous-hyperemic and tu-
morous EBTB are associated with the worst prognosis (Figure 2);
however, while the ﬁbrostenotic subtype is not associated with a
worsening of the bronchial narrowing until complete ﬁbrotic
bronchial obstruction, the other three subtypes result in ﬁbroste-
nosis in the majority of the patients (Kashyap and Solanki, 2014;
Chung and Lee, 2000; Shim, 1996). Furthermore, because changesseous material (A); ﬁbrostenotic endobronchial tuberculosis: severe pinpoint lobar
Table 3
Bronchoscopic features of endobronchial tuberculosis (EBTB) subtypes according to Chung classiﬁcation (Chung and Lee, 2000).
EBTB Subtype Bronchoscopic features
Non speciﬁc bronchitic mildly swollen and/or hyperemic mucosa
Edematous-hyperemic severely swollen and hyperemic mucosal surface
Actively caseating edematous and hyperemic tracheobronchial mucosa covered with a large amount of whitish cheese-like material. Usual luminal narrowing.
Granular severely inﬂamed mucosa with scattered rice-like nodules on the surface
Tumorous endobronchial mass whose surface is often covered with caseous material and may totally occlude the bronchial lumen
Ulcerative ulcerate tracheobronchial mucosa
Fibrostenotic tracheobronchial narrowing of the bronchial lumen due to ﬁbrosis
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treatment without any further signiﬁcant variations, therapeutic
outcomes can be estimated by follow-up bronchoscopy performed
during the ﬁrst three months of therapy, with the only exception of
the tumourous type. This group of lesions, which is mainly due to
an intrathoracic tuberculous lymph node erosion and protrusion
into the bronchus (Figure 3), deserves a close and long-term
follow-up because its evolution may be unpredictable and
bronchial stenosis may occur in a late phase of the disease (Chung
and Lee, 2000; Kim et al., 1993; Lee et al., 1992). Unfortunately,
antibiotics play a limited role in preventing bronchostenosis (Um
et al., 2008). Therefore, prompt diagnosis and mechanical
treatment are of paramount importance in EBTB, in order to
minimize the resultant bronchial strictures (Chung and Lee, 2000).
Bronchoscopic diagnostic techniques for patients with endobronchial
tuberculosis
Bronchoscopy may provide support for bacteriological and
histological diagnosis of EBTB, since sputum examinations show a
low diagnostic yield in the majority of the cases (Sahin and Yildiz,
2013; Chung and Lee, 2000; Hou et al., 2014; Kim et al., 1993; Lee
et al., 1992; Aggarwal et al., 1999). Furthermore, because
endobronchial tuberculosis may mimic endobronchial neoplasms,
in this context endoscopy plays a key role to rule out the presence
of malignancies (Altin et al., 1997; Ozkaya et al., 2012; Shim, 1996).
Endobronchial biopsy (EBB) is the most reliable sampling
method for EBTB diagnosis, with a sensitivity of 72.2-100.0% in the
detection of granulomas (Altin et al., 1997; Ozkaya et al., 2012; Lee
and Chung, 2000; Hou et al., 2014; Xue et al., 2011; Qingliang and
Jianxin, 2010; Lee et al., 1992; Aggarwal et al., 1999; Hoheisel et al.,
1994).
Altin et al. demonstrated a signiﬁcantly better histological yield
of EBB than endobronchial needle aspiration (respectively 84.0% vsFigure 3. Tumorous lesion at the level of the main carina due to a subcarinal lymph
node protrusion into the bronchial tree. Chest computed tomography view at the
top.19.0%, respectively) in 42 subjects with EBTB (Altin et al., 1997). On
the other side, smear and culture of bioptic tissues shows a wide
sensitivity (8.0-100.0%), but few studies are available on their
diagnostic performance (Ozkaya et al., 2012; Hou et al., 2014;
Aggarwal et al., 1999; Hoheisel et al., 1994). Beside the most
frequently used forceps biopsies, cryobioprobes have been
described to successfully diagnose TB endobronchial masses (Chou
et al., 2013).
Real-time PCR can reduce the time to diagnosis, improving
patient prognosis (bronchial stenosis), showing a high sensitivity
and speciﬁcity. Hou et al. reported on a sensitivity of 89.2% in a
cohort of 74 patients with EBTB, signiﬁcantly higher than that of
sputum (4.1%) and bronchial brush smear microscopy (39.2%).
Furthermore, employing the ABI PRISM 7500HT real-time PCR
(Applied Biosystems, Foster City, CA, USA), the Authors showed a
higher PCR sensitivity in granular, caseating and ulcerative EBTB
than in edematous-hyperemic and ﬁbrostenotic subtypes (Hou
et al., 2014).
Studies based on traditional bacteriology on BW and BAL
revealed a diagnostic yield of 10.0-37.0% and 12.5%-62.5% for smear
microscopy and culture, respectively (Sahin and Yildiz, 2013; Altin
et al., 1997; Ozkaya et al., 2012; Aggarwal et al., 1999). Ozkaya et al.
demonstrated in a group of 21 patients that the highest smear and
culture positivity was found in granular subtype (75%), while both
resulted negative in patients with non speciﬁc bronchitic and
ﬁbrostenotic EBTB (Ozkaya et al., 2012).
Bronchoscopic treatment for patients with endobronchial tuberculosis
TB tracheobronchial stenosis, which is the commonest cause of
benign stenosis in high TB incidence countries, represents the
worst complication of EBTB. Different degrees of tracheobronchial
strictures can occur, from slight luminal narrowing to complete
obliteration, thus determining segmental, lobar or whole lung
atelectasis despite the administration of effective TB therapy (Um
et al., 2008). Left-side bronchi are more frequently involved
because they are anatomically compressed by the aortic arch and
TB is more often located in the left-sided lymph nodes (Lee et al.,
2010; Lim et al., 2011; Verma et al., 2012; Iwamoto et al., 2004).
These clinical conditions, which may cause respiratory failure,
deserve an immediate endoscopic evaluation and management
(Aggarwal et al., 1999; Verma et al., 2012; Iwamoto et al., 2004).
Bronchoscopic procedures (ablation and dilation techniques)
represent an alternative and less invasive strategy than conven-
tional surgery in the management of stenosis resulting from
endobronchial disease, particularly when surgical treatment is
contraindicated or in case of multi-level stenosis (Kashyap and
Solanki, 2014; Lim et al., 2011; Verma et al., 2012; Iwamoto et al.,
2004) (Table 4).
To date, only one case series has described TB cavity collapse
performed by a bronchoscopy (Corbetta et al., 2016). Interestingly,
Corbetta et al. described a minimally invasive lung collapse
therapy recommended for emphysema-associated hyperinﬂation,
Table 4
Summary of bronchoscopic treatment options described in literature.
Therapy Technique Bronchoscope
used
Scientiﬁc
evidence
level
Indications Adverse events
Dilation Rigid bronchoscope (Iwamoto et al., 2004; Low et al., 2004; Ryu
et al., 2006)
Rigid RCSs Fibrostenotic EBTB dilation NR
Metal bougie (Lim et al., 2011; Ryu et al., 2006) Rigid RCSs Fibrostenotic EBTB dilation NR
Balloon (Iwamoto et al., 2004; Ryu et al., 2006; Shitrit et al.,
2010; Ferretti et al., 1995; Lee et al., 1999; Cho et al., 2015)
Rigid and
ﬂexible
RCSs Fibrostenotic EBTB dilation
(particularly in presence of annular
cicatricial stenosis)
Mild haemoptysis,
transient fever
Stents placement
(silicone and metallic)
(Lim et al., 2011; Verma et al., 2012; Iwamoto et al., 2004; Low
et al., 2004; Ryu et al., 2006; Bolliger et al., 2006; Cavaliere
et al., 1988)
Rigid
(silicone)
Rigid and
ﬂexible
(metallic)
RCSs Fibrostenotic EBTB dilation
(particularly in presence of
tracheo-bronchial malacia)
Granulation tissue
growth, mucostasis,
stent migration
Mitomycin-C application
(Cary et al., 2015; Faisal et al., 2016; Penaﬁel et al., 2006)
Rigid and
ﬂexible
CRs Fibrostenotic EBTB relapse
prevention after dilation
None
Ablation Nd-YAG laser (Lim et al., 2011; Low et al., 2004; Ryu et al., 2006;
Bolliger et al., 2006; Cavaliere et al., 1988)
Rigid and
ﬂexible
RCSs Fibrostenotic EBTB treatment NR
KTP laser (Qiu-Sheng and Cai-Ping, 2013) Flexible CRs Tumorous EBTB treatment None
Carbon dioxide laser (Cary et al., 2015; Tong and Van Hasselt,
1993)
Rigid CS Fibrostenotic EBTB treatment None
Electrocautery (Shim, 1996; Amat et al., 2012) Rigid CS Fibrostenotic (web-like stenosis)
and tumorous EBTB treatment
None
APC (Jin et al., 2013) Flexible RCS Tumorous EBTB treatment in
stenosis prevention
Mild bleeding,
laryngeal spasm, cough
Cryotherapy (Marasso et al., 1993; Mu et al., 2011) Rigid and
ﬂexible
RCSs Fibrostenotic EBTB treatment and
granular EBTB treatment in stenosis
prevention
Mild bleeding
RCS: retrospective cohort study; CS: case series; CR: case report; NR: not reported; EBTB: endobronchial tuberculosis; Nd-YAG: neodymium:yttrium aluminium garnet; KTP:
potassium titanyl phosphate; APC: Argon Plasma Coagulation.
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(EBVs) in four TB patients (with multi-drug resistant and difﬁcult-
to-treat extensive disease) and in one patient with atypical
mycobacteriosis (Sciurba et al., 2010). The patients were consid-
ered not eligible for surgery owing to a large pulmonary
involvement or serious clinical conditions. EBVs and medical
therapy resulted in cavity collapse in all patients (partial in one and
complete in four), and sputum smear became negative within 3-
5 months after EBVs implantation.
No complications occurred and the valves were removed in
3 out of 5 patients after 8 months and no relapses were recorded
after 15 months of follow-up (Corbetta et al., 2016).
Dilation techniques for tuberculosis patients with TB-related stenosis
Bronchoscopic airway dilation may be accomplished through
rigid or ﬂexible bronchoscopes.
The rigid bronchoscope itself provides dilation with the shear
mechanics of the scope (Xue et al., 2011; Shim, 1996; Iwamoto
et al., 2004; Watanabe et al., 1988; Low et al., 2004; Ryu et al.,
2006). Metal bougie dilators provide the same effect but dilation
performed by this technique, described only in a few studies (Lim
et al., 2011; Ryu et al., 2006), may damage the mucosa (Xue et al.,
2011; Shim, 1996). Balloon dilation is a minimally invasive and safe
technique that can be performed with ﬂexible bronchoscopes, by
gentle balloon inﬂation through the stricture. It is particularly
appropriate for annular cicatricial stenosis, since the balloon
dilates the stenotic bronchus by expanding radially. As suggested
by Shitrit et al., ﬁbrotic process with ﬁxed stenosis may be more
responsive to a successful balloon dilation than those with active
inﬂammation, calciﬁcation, or in whom the surrounding cartilage
is destroyed (malacia). This approach is frequently the ﬁrst
treatment for tracheobronchial stenosis, with long term successful
results ranging from to 6.3% to 73.0%. The wide effectiveness range
depends on different conditions of the treated tracheobronchial
walls among studies (Iwamoto et al., 2004; Ryu et al., 2006; Ferretti
et al., 1995; Lee et al., 1999; Cho et al., 2015). When balloon dilationfails and more than one dilation is required, stent procedures are
needed.
Airway stenting is an important strategy for managing
tracheobronchial stenosis. Stenting is usually performed after
balloon dilatation when the patient has a bacteriological conver-
sion (Iwamoto et al., 2004). The major indications for the
placement of airway stents are: patency of the central airways,
racheobronchial malacia, ﬁstulas due to TB erosion. Because stent-
related complications are frequently observed in patients with
benign stenosis caused by TB, and airway remodelling usually
follows brochoscopic interventions, a removable stent should be
selected (e.g., silicone stents such as Dumon stents (Dumon et al.,
1996)). Furthermore, the dynamic properties of self-expandable
metallic stents (such as Ultraﬂex and Gianturco stents) may lead to
their fracture due to metal fatigue with severe repeated coughing
(Iwamoto et al., 2004; Madden et al., 2006; Chung et al., 2011;
Gottlieb et al., 2009).
Iwamoto et al. reported successful long-term outcomes of six
patients treated with Dumon stents (both tubular and Y-shaped) to
re-establish the patency of the central airway, without any severe
complications in comparison with cases treated with expandable
metallic stent (Ultraﬂex). They described the growth of granulation
tissue more frequently in Ultraﬂex stent patients (between the
mesh of uncovered Ultraﬂex stents and at the edges of the covered
ones) than in those treated with silicone stents (Iwamoto et al.,
2004). Interestingly, the Authors employed radial EBUS probes to
assess the condition of the bronchial wall and to diagnose
cartilaginous bronchomalacia.
Lowetal. described animmediateand long-termclinicalrecovery
in 7/11 (63.6%)patients treatedwith Dumon stents (Low et al., 2004);
similar successful ﬁndings were observed by Ryu et al. for 75 patients
with tracheobronchial tuberculous stenosis (Ryu et al., 2006): they
placed silicon stents (both Dumon and Natural stents) which
provided immediate symptomatic relief and improved lung function
in 88% of the cases. After airway stabilization, stents were
successfully removed in 49/75 (65%) patients after a median of
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migration (51%), granuloma formation (49%), mucostasis (19%), and
restenosis (40%) (Ryu et al., 2006).
Lim et al. described the outcome of 71 patients who were
treated with silicone stenting for post-TB tracheobronchial
stenosis. The Authors described immediate symptom relief in
100% of cases with a rate of successful stent removal of 56% after
12.5 months. Granulation, mucostasis and stent migration were
the most common complications (Lim et al., 2011). Similar ﬁndings
were described by Verna et al. who safely removed a Natural stent
in 31/41 (76%) patients, after a median of 18 months (Verma et al.,
2012).
Zhou et al. recently evaluated the long-term effects associated
with the temporary placement of metallic stents in patients with
benign tracheobronchial stenosis (post-TB strictures in the
majority of the cases). Uncovered metallic stents with ﬂexible
bronchoscope were placed in 40 patients and, then, easily removed
after a median of 18 days. Only mild complications (granulation
tissue growth, stent migration, or mal-expansion) occurred. After a
median of 27 months following stent removal, 22 patients were
symptom-recurrence free. Growth of granulation tissue and
tracheobronchial malacia were independent factors of poor
prognosis (Zhou et al., 2015).
Other Authors studied prognostic factors associated with
successful airway stenting in patients with EBTB-related stenosis
(Lee et al., 2010; Lim et al., 2011).
Lim et al. demonstrated in a group of 71 patients treated with
silicon stents that successful stent removal was independently
associated with atelectasis lasting < 1 month before bronchoscopy
intervention and absence of complete lobar atelectasis, which is
suggestive of extensive cicatricial healing and dense ﬁbrotic
changes (Lim et al., 2011). Similar ﬁndings were observed by Lee
et al. who found that parenchymal calciﬁcation and bronchiectasis
in atelectasis distal to bronchial stenosis at CT scans are associated
with treatment failure (Lee et al., 2010), supporting the hypothesis
that chronic changes of lung parenchyma or bronchi are
unfavourable prognostic factors (Lim et al., 2011). On the contrary,
TB activity at the time of intervention, mucus plugging, the extent
of airway narrowing, and volume loss on CT scans did non affect
the ﬁnal outcome (Lee et al., 2010).
In patients with post-TB stenosis, stents are usually removed
when stenosis is reduced (i.e., patency is achieved after 12-18
months) (Verma et al., 2012; Colt and Dumon, 1995; Martinez-
Ballarin et al.,1996; Cary et al., 2015). In case of premature removal,
emergency reinsertion may be necessary. On the contrary, stents
placed for a prolonged period are associated with a higher
probability of stent-related complications. The decision of stent
removal is usually based on clinical and functional stability (Verma
et al., 2012). Verma et al. who carried out a retrospective study
enrolling 41 patients with post-TB stenosis who underwent
silicone stent placement and removal, showed that the air pockets
(tracheobronchial air column length in the space between stent
outer surface and the adjacent airway wall) were signiﬁcantly
longer in patients with successful stent removal than in those who
failed (Verma et al., 2012).
A novel technique has been recently described to prevent
stenosis relapse after dilation.
Mitomycin-C, which is an antineoplastic agent inhibiting
ﬁbroblast proliferation and modulating wound healing and
scarring, was administered topically with saturated pledgets
applied by forceps biopsy (0.4-0.5 mg/ml) in a few cases, as an
adjunct therapy to bronchoscopic procedures (e.g., laser treatment
and balloon dilation). It can prevent re-stenosis, and then replace
airway stenting in tracheobronchial strictures secondary to EBTB
(Cary et al., 2015; Faisal et al., 2016; Penaﬁel et al., 2006).Ablative techniques in tuberculosis patients with endobronchial
disease
Ablative techniques include heat and cold therapies. Ablative
heat modalities are represented by laser therapy, electrocautery,
and Argon Plasma Coagulation (APC) (Kashyap and Solanki, 2014;
Shim, 1996).
Laser resection is based on laser energy delivered via rigid and/
or ﬂexible bronchoscopes. Several laser types are available. The
neodymium:yttrium aluminium garnet (Nd-YAG) equipment is the
most widely used for bronchoscopic interventions having sufﬁ-
cient power to vaporise tissues and to produce an effective
coagulation (Bolliger et al., 2006). Laser therapy is recommended
for endobronchial malignant lesions but also for EBTB-related
stenosis (Shim, 1996). Cavaliere et al. treated six patients with TB
tracheobronchial stenosis: normal bronchial patency was not fully
achieved, but ventilation signiﬁcantly improved (Cavaliere et al.,
1988). The successful administration of Nd-YAG laser therapy was
also described by Low et al. and Ryu et al. who cut ﬁbrous bands in
21 and 13 patients with TB stenosis, respectively, and by Lim et al.
who treated 14 web-like stenosis before stent placement (Lim
et al., 2011; Low et al., 2004; Ryu et al., 2006).
The efﬁcacy of potassium titanyl phosphate (KTP) laser was
described in two case reports of tumorous EBTB obstructing
tracheal and right main bronchial lumen (Qiu-Sheng and Cai-Ping,
2013). Cary et al. (2015) and Tong and Van Hasselt (1993) reported
on the carbon dioxide laser resection in ﬁve patients with TB
tracheobronchial strictures.
Electricity for tissue heating (electrocautery or diathermy) can
be used for TB lesions. Electrons ﬂow between the probe and the
target tissue (voltage difference), generating heat for tissue
coagulation due to the higher resistance of the target tissue.
APC, a non-contact treatment mode, is based on ionized argon gas
jet ﬂow (i.e., plasma) to conduct electrons. Unlike laser therapy
which requires general anaesthesia and is associated with higher
costs, diathermy and APC can be used in an outpatient setting with
a ﬂexible bronchoscopy and conscious sedation (Bolliger et al.,
2006).
Electrocautery was prescribed for patients with TB web-like
stenosis and in tumorous type EBTB (Shim,1996; Amat et al., 2012).
Bronchoscopic APC is a safe therapy administered in cases of
tumorous EBTB to prevent luminal stenosis. Jin et al. described the
long-term outcome of 41 patients with tumorous EBTB who were
exposed to APC and TB drugs in comparison with a control group
with similar endoscopic ﬁndings who received only antibiotics.
The Authors showed that the APC group (mean of 3 treatments
before a complete recovery) achieved a cure rate of 100% vs. 84.6%
in the control group. Furthermore, APC-treated patients showed a
faster recovery (Jin et al., 2013). Cryotherapy, which consists of
cold-induced cell death by repeated cycles of cold application
followed by thawing, is a safe approach to treat TB stenosis without
any risks of airway ﬁre or bronchial wall perforation (Kashyap and
Solanki, 2014; Marasso et al., 1993). Marasso et al. described for the
ﬁrst time the successful application of this ablative technique with
the rigid bronchoscope in 12 patients with post-TB stenosis
(Marasso et al., 1993).
Recently, Mu et al. found that bronchoscopic cryotherapy can
improve granular EBTB and prevent progressive stenosis. They
evaluated 38 patients treated with cryotherapy through ﬂexible
instruments (both bronchoscope and cryoprobes) and TB drugs in
comparison with 38 patients who received only anti-TB drugs.
Treatment success rate was 100% in the cryotherapy arm exposed
to a mean of 4 applications per patient vs. 78.9% in those treated
with the only anti-TB drugs. The time to recovery was faster in the
cryotherapy arm and no severe adverse events were reported (Mu
et al., 2011).
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TB lymphadenitis (TBLA) is the most common extra-pulmonary
TB disease (Norbis et al., 2014). The diagnosis of hilar and
mediastinal TBLAs can be challenging, occurring as isolated
intrathoracic adenopathies without any parenchymal involvement
and any speciﬁc radiological and clinical features (Navani et al.,
2011). A deﬁnite diagnosis is essential to rule out sarcoidosis or
malignancies (i.e. lymphoma and lung cancer) (Navani et al., 2011;
Eom et al., 2015).
The endoscopic approach is now considered the preferred
means to collect biological samples. This accurate and minimally
invasive technique may avoid invasive surgical procedures such as
mediastinoscopy and video assisted thoracoscopy (Navani et al.,
2011; Eom et al., 2015).
TBLA diagnosis relies on smear microscopy and culture, in
association with speciﬁc cytological and histological features
(Navani et al., 2011; Eom et al., 2015).
Conventional TBNA with both cytology (21-22 gauge) and
histology (19 gauge) needles has been the ﬁrst bronchoscopic
technique to diagnose TBLA, showing a sensitivity of 65.0-100.0%
and a speciﬁcity of 100.0%, with a good safety proﬁle (Cetinkaya
et al., 2002; Cetinkaya et al., 2004; De Wet et al., 2015; Bilaceroglu
et al., 2004; Baran et al., 1996).
With the implementation of endobronchial ultrasounds, EBUS-
TBNA has become the standard for the diagnosis of a mediastinal
lymphadenitis (Navani et al., 2011; Hassan et al., 2011; Ye et al.,
2015; Li et al., 2015). In 2011, Hassan et al. and Navani et al.
demonstrated for the ﬁrst time its effectiveness and safety (Qiu-
Sheng and Cai-Ping, 2013; Hassan et al., 2011).
In a retrospective cohort study recruiting 19 patients with TBLA,
Hassan et al. (2011) found a sensitivity of 95.0% and a speciﬁcity of
100.0%. They detected granulomas with necrosis in 16 patients,
whereas 12 had positive culture for Mycobacterium tuberculosis.
The high accuracy was conﬁrmed by Navani et al., who described a
sensitivity of 94.0% in 146 patients with TBLA. Furthermore, they
showed that necrosis on needle aspiration and sampling more than
one lymph node are associated with a higher diagnostic yield
(Navani et al., 2011).
Two meta-analyses recently published found a sensitivity and
speciﬁcity of EBUS-TBNA in the diagnosis of TBLA of 80.0% and
100.0%, respectively (Ye et al., 2015; Li et al., 2015).
Few studies on EBUS-TBNA assessed the utility of PCR (both
nested and real-time), showing sensitivity and speciﬁcity of 36.8-
56.7% and 100.0%, respectively (Eom et al., 2015; Hassan et al.,
2011; Senturk et al., 2014; Geake et al., 2015). The diagnostic
accuracy of NAAT with EBUS-TBNA can improve when histology
and conventional bacteriology are performed (Eom et al., 2015).
To date, few studies have described the performance of Xpert
MTB/RIF in the diagnosis of mediastinal TBLA by EBUS-TBNA
(Table 1). Dhasmana et al. ﬁrstly demonstrated an overall sensitivity
and speciﬁcity of 72.6% and 96.3%, respectively, in 88 culture positive
cases. Furthermore, Xpert correctly detected two rifampin-resistant
cases within 24 hours (Dhasmana et al., 2014). More recently, two
other studies conﬁrmed the good diagnostic yield of this method
(Dhooria et al., 2016a; Lee et al., 2017).
Transesophageal endoscopic ultrasound-guided ﬁne needle
aspiration (EUS-FNA) provides access to inferior mediastinum, left
paratracheal area and aorto-pulmonary window and is now
considered a complementary technique to EBUS-TBNA in diagnos-
ing and staging non small cell lung cancer (Vilmann et al., 2015). Its
utility has also been conﬁrmed in diagnosing intrathoracic TBLA
(Sharma et al., 2016; Fritscher-Ravens et al., 2011; Puri et al., 2010).
In recent years, the transesophageal approach has also been
successfully performed with an ultrasound bronchoscope, by a
trained pulmonologist (Mondoni et al., 2015). This technique,named endoscopic ultrasound (with bronchoscope) ﬁne needle
aspiration or EUS-B-FNA, has successfully been used for TB
diagnosis involving mediastinal lymph nodes, when EBUS was
technically complicated or in patients unsuitable for a trans-
bronchial approach (Mondoni et al., 2015; Oki et al., 2013; Dhooria
et al., 2015).
Conclusions
Bronchoscopy can play a key role in the management of
difﬁcult-to-treat TB patients. When sputum cannot be collected, it
can be a safe and highly reliable method. Moreover, it can be
helpful for the evaluation of the lower respiratory airways, the
detection of an endobronchial disease, and for sampling hilar and
mediastinal lymph nodes. Histology, bacteriology and real-time
PCR (i.e., Xpert assay), performed on broncoscopic specimens, may
improve the diagnostic yield.
Future studies are needed to better deﬁne the role of the newer
bronchoscopic technologies (both guidance methods and sampling
techniques) in the diagnostic TB pathway to improve early TB
diagnosis. Furthermore, future investigations could better assess
the role of bronchoscopic therapies, in combination with anti-TB
drugs, particularly when more invasive surgical procedures are not
recommended.
On the basis of some preliminary results, a widespread
implementation of bronchoscopic techniques in reference centres
might increase the case detection rate of both drug-susceptible and
-resistant TB and the treatment success rate of complicated patients.
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